European Journal of Immunology
Cross‐Neutralizing and Broadly Neutralizing Human Antibodies Against Nonenveloped Viruses
By Sarah Marchand, Samy Taouli and Dorian McIlroy.
Abstract
ABSTRACT Neutralizing antibodies (NAbs) play a central role in antiviral protection and are increasingly considered for prophylactic or therapeutic use, particularly against viruses lacking effective antiviral treatments. While research has predominantly focused on NAbs targeting the envelope proteins of enveloped viruses, nonenveloped viruses remain major human pathogens for which broad antibody responses are less well characterized. Recent work has identified several cross‐ and broadly neutralizing antibodies generated during human infection with nonenveloped viruses, revealing different mechanisms of action and new structural vulnerabilities. This review provides an overview of these NAbs, summarizes their mechanisms of action when these have been identified, and highlights recent advances relevant to antiviral antibody development and vaccine research.
Keywords
- Monoclonal and Polyclonal Antibodies Research
- Open access
Source
Published in European Journal of Immunology. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
